@inproceedings {17091, title = {Genetic analysis of the double resistance phenotype to β(1,3)D-glucan synthase from the Schizosaccharomyces pombe mutant pbr1-8}, journal = {European Journal of Biochemistry - The FEBS Journal}, volume = {271}, year = {2004}, month = {2004-06-04 00:00:00}, pages = {23-24}, publisher = {Wiley-Blackwell }, address = {Warsaw, Poland}, abstract = {
The cell wall can be considered a specific target in the development of new\ antifungal agents. The biosynthesis of (1,3)β-D-glucan, one of the structural\ elements of the fungal cell wall, represents a valuable model for morfogenetic\ studies. We have identified four bgs (beta glucan synthesis) genes that probably\ are the catalytic subunits of four different (1,3)β-D-glucan synthase activities in\ S. pombe. bgs4+ was cloned from a cosmid clone located in the same region\ where we described two genetically linked mutant genes, both related with the
(1,3)β-D-glucan synthesis: cwg1-1, a termosensitive mutant affected in the (1,3)β-D-glucan synthase catalytic subunit and pbr1-8, implicated in the resistance to\ antifungal drugs that specifically inhibit the (1,3)β-D-glucan synthase activity.
We found that cwg1+ and bgs4+ are the same gene. On the other hand, bgs4+\ does not suppress the recessive phenotype of a pbr1{\textendash}8 mutant. By the contrary, a\ bgs4D/pbr1{\textendash}8 diploid, containing a plasmid expressing bgs4+ under the control of the thiamine-repressible nmt1+ promoter 81X, is resistant to the antifungals when the promoter is repressed and sensitive when it is induced. Besides, bgs4+ cloned from a pbr1{\textendash}8 mutant, induces a resistant phenotype in a bgs4D but not in a bgs4+ strain. Therefore, bgs4+ is at least partially responsible for the resistant phenotype of pbr1{\textendash}8 mutant. These results suggest that it is possible the existence of a second gene, very tightly linked to bgs4+, that would be responsible for an additional resistance phenotype. We performed a bgs4+ deletion analysis from a pbr1{\textendash}8 strain containing the thiamine-repressible plasmid p81X-bgs4+, to maintain the deletion strain viable. Deletion of the complete bgs4pbr1-8 ORF suppressed the mutant phenotype. However, deletions of (1) 1 Kb promoter region plus ATG codon, (2) 200 bases of 5 end ORF, or (3) 1 Kb of 3 end ORF showed, in the three cases, that the truncated Bgs4p were not functional but the resulting bgs4pbr1-8 strains displayed the resistance phenotype. We are currently performing new bgs4+ partial deletions and complementation tests. These and new results will be discussed.